Tetracycline and trimethoprim/sulfamethoxazole at clinical laboratory: Can they help to characterize Staphylococcus aureus carrying different SCCmec types?
Rev. Soc. Bras. Med. Trop
; 46(1): 100-102, Jan.-Feb. 2013. tab
Article
в En
| LILACS
| ID: lil-666803
Ответственная библиотека:
BR1.1
ABSTRACT
INTRODUCTION:
Methicillin-resistant Staphylococcus aureus (MRSA) can be difficult to detect at the clinical practice.METHODS:
We analyzed 140 MRSA isolates from inpatients to correlate the antimicrobial susceptibility with the SCCmec types.RESULTS:
Type III (n = 63) isolates were more resistant to ciprofloxacin, clindamycin, cloramphenicol, erythromycin, gentamicin, and rifampin than type IV (n = 65) ones (p < 0.05). Moreover, type IV isolates were susceptible to tetracycline (100%) and trimethoprim/sulfamethoxazole (98%), while type III isolates presented resistance to them.CONCLUSIONS:
In regions where these SCCmec types are prevalent, the detection of specific resistant phenotypes could help to predict them, mainly when there are no technical conditions to SCCmec typing.Key words
Search on Google
База данных:
LILACS
Основная тема:
Tetracycline
/
Trimethoprim, Sulfamethoxazole Drug Combination
/
Drug Resistance, Multiple, Bacterial
/
Methicillin-Resistant Staphylococcus aureus
/
Anti-Bacterial Agents
Пределы темы:
Humans
Язык:
En
Журнал:
Rev. Soc. Bras. Med. Trop
Тематика журнала:
MEDICINA TROPICAL
Год:
2013
Тип:
Article